Cargando…

Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections

OBJECTIVE: To assess the effect of a pharmacist-driven, polymerase chain reaction (PCR)−based nasal screening protocol for methicillin-resistant Staphylococcus aureus (MRSA) on vancomycin therapy duration and on rates of adverse drug events and 30-day hospital readmission. PATIENTS AND METHODS: From...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woolever, Nathan L., Schomberg, Rachel J., Cai, Songlin, Dierkhising, Ross A., Dababneh, Ala S., Kujak, Richard C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557184/ https://www.ncbi.nlm.nih.gov/pubmed/33083704 http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.002

Ejemplares similares

1489. Safety and Performance of a Pharmacist-Driven Nasal MRSA PCR Protocol for De-escalation of Empiric Vancomycin for Suspected Pneumonia at an Academic Medical Center
por: Meng, Lina, et al.
Publicado: (2020)

59. Impact of Pharmacist-Led De-Escalation of MRSA Therapy Using MRSA Nasal PCR
por: Salvatus, Marc, et al.
Publicado: (2021)

Effect of Pharmacist Audit on Antibiotic Duration for Pneumonia and Urinary Tract Infection
por: Thomas, Ashley A., et al.
Publicado: (2021)

2010. A Significant Reduction in Empiric Vancomycin Days of Therapy for Suspected MRSA Pneumonia in Adult Non-ICU Patients After Implementation of a Rapid MRSA Nasal PCR Test with Antimicrobial Stewardship Intervention
por: Markoski, Nikola, et al.
Publicado: (2019)

Vancomycin resistance among MRSA
por: Kumar, V. Anil
Publicado: (2012)

Nasal Decolonisation of MRSA
por: Mantle, Peter
Publicado: (2019)

1451. Predictive Values of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia
por: Chou, Man Ting, et al.
Publicado: (2018)

1215. The Impact of MRSA Nasal PCR on Antibiotic De-escalation
por: Silverman, Adam, et al.
Publicado: (2023)

1994. Impact of Pharmacist-initiated MRSA Nasal PCR Protocol on Pneumonia Therapy in a Community Teaching Hospital
por: Pham, Selena, et al.
Publicado: (2019)

160. Measuring the Impact of PCR-based MRSA Nares Screening on Vancomycin Use and Duration of Vancomycin Among Pneumonia Patients at an Academic Medical Center
por: Stromberg, Joseph, et al.
Publicado: (2023)

Enteral Vancomycin to Eliminate MRSA Carriership of the Digestive Tract in Critically Ill Patients
por: Buitinck, Sophie H., et al.
Publicado: (2022)

1804. Quality Improvement Project to improve empiric antibiotic therapy for skin and soft tissue infections using the nasal MRSA PCR
por: Kasule, Sabirah N, et al.
Publicado: (2022)

2948. Pediatric Clinical Outcomes of MRSA PCR Utilization for Anti-MRSA De-escalation
por: Demirhan, Salih, et al.
Publicado: (2023)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

110. MRSA nasal swab as a stewardship tool to guide IV Vancomycin in diabetic foot infections
por: Lazo-Vasquez, Alex, et al.
Publicado: (2021)

2153. Clinical Impact of Addition of Oropharynx MRSA PCR to Anterior Nares MRSA PCR for Patients Admitted with Pneumonia
por: Kessler, Michael, et al.
Publicado: (2019)

306 Switch from MRSA PCR to Agar for Nasal Screening Does Not Increase Transmission
por: Strymish, Judith, et al.
Publicado: (2014)

2157. Evaluation of the Utility of the MRSA Nasal PCR Assay in a Community Healthcare System
por: Hobbs, Athena L V, et al.
Publicado: (2019)

1191. The Implementation of Nasal MRSA PCR for Pneumonia and Association with Antibiotic Use and Clinical Outcomes
por: Fenlon, Luke A, et al.
Publicado: (2023)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
por: Graber, Christopher J., et al.
Publicado: (2007)

Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
por: Kwok, Gabriella M. L., et al.
Publicado: (2013)

Acute MRSA Sinusitis with Intracranial Extension and Marginal Vancomycin Susceptibility
por: Kumar, Parvathi S., et al.
Publicado: (2013)

155. Use of MRSA PCR and Antimicrobial Stewardship Intervention to Limit Anti-MRSA Therapy in Respiratory Tract Infections at a Community Teaching Hospital
por: Politis, Paula A, et al.
Publicado: (2023)

116. Leveraging the Use of the PCR-based Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab in the Emergency Department to Optimize Vancomycin Use in the Inpatient Setting
por: McManus, Dayna, et al.
Publicado: (2020)

Suspected Horse-to-Human Transmission of MRSA ST398
por: van Duijkeren, Engeline, et al.
Publicado: (2011)

Predictive Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab for MRSA-positive Culture in Hospitalized Veterans
por: Fox, Teresa, et al.
Publicado: (2017)

Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection
por: DeKerlegand, Alaina, et al.
Publicado: (2023)

79. Outcomes Associated with the Utilization of the Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Polymerase Chain Reaction (PCR) Assay to De-escalate Vancomycin Therapy in Patients with Suspected Pneumonia at a Rural Community Hospital
por: Tirupathi, Raghavendra, et al.
Publicado: (2020)

1999. Does Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus PCR Nasal Screening Decrease Time to De-Escalation of MRSA Coverage in Patients with Pneumonia?
por: Waters, Dustin, et al.
Publicado: (2019)

Nasal Screening for MRSA: Different Swabs – Different Results!
por: Warnke, Philipp, et al.
Publicado: (2014)

1809. Improved Vancomycin Utilization With Rapidly Available Xpert MRSA/SA BC PCR and Microbiologist Case Review
por: Li, Lisa, et al.
Publicado: (2018)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
por: Neoh, Hui-min, et al.
Publicado: (2007)

Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
por: Bhise, Ketki, et al.
Publicado: (2018)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab
por: Kalinoski, Michael, et al.
Publicado: (2023)

Nasal and extra nasal MRSA colonization in hemodialysis patients of north-west of Iran
por: Ghavghani, Fatemeh Ravanbakhsh, et al.
Publicado: (2019)

MRSA PCR improves sensitivity of detection of colonization in neonates
por: Hiermandi, Nahid, et al.
Publicado: (2023)

The Prevalence of MRSA Nasal Carriage in Preoperative Pediatric Orthopaedic Patients
por: Walrath, J. J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5aqe2ut9ib8ls27vvak0m2v8jl